Lisata Therapeutics, Inc.
LSTA· Nasdaq
LSTALisata Therapeutics, Inc.
Released Mar 12, 2026, after the close
10-K filed Mar 12, 2026, 71 days after period end · 0000320017-26-000023
derived · Computed from the longer spans the company filed.
No earnings release is on file for this quarter. Its figures came with the 10-K.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $100.00K | $1.00M | $0.00 | — |
| Net Income | -$2.95M | -$4.61M |
Lisata Therapeutics, Inc. · CIK 320017 · Engraved from SEC EDGAR
| -$5.37M |
| -$5.99M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
